Candriam S.C.A. Reduces Holdings in HCA Healthcare, Inc. $HCA

Candriam S.C.A. decreased its position in HCA Healthcare, Inc. (NYSE:HCA) by 10.6% during the 1st quarter, according to its most recent disclosure with the SEC. The fund owned 90,263 shares of the company’s stock after selling 10,738 shares during the period. Candriam S.C.A.’s holdings in HCA Healthcare were worth $42,716,000 as of its most recent SEC filing.

Other large investors also recently modified their holdings of the company. Nordea Investment Management AB grew its stake in shares of HCA Healthcare by 11.2% in the 4th quarter. Nordea Investment Management AB now owns 1,084,590 shares of the company’s stock worth $507,393,000 after buying an additional 108,849 shares during the last quarter. Nomura Asset Management Co. Ltd. boosted its holdings in HCA Healthcare by 6.2% in the fourth quarter. Nomura Asset Management Co. Ltd. now owns 64,237 shares of the company’s stock worth $29,990,000 after acquiring an additional 3,724 shares in the last quarter. Hudson Bay Capital Management LP raised its position in shares of HCA Healthcare by 154.5% in the 3rd quarter. Hudson Bay Capital Management LP now owns 4,693 shares of the company’s stock worth $2,000,000 after purchasing an additional 2,849 shares during the last quarter. Advisors Capital Management LLC grew its position in HCA Healthcare by 61.5% during the 4th quarter. Advisors Capital Management LLC now owns 6,836 shares of the company’s stock valued at $3,192,000 after purchasing an additional 2,604 shares during the last quarter. Finally, CWA Asset Management Group LLC raised its holdings in HCA Healthcare by 1,062.4% in the fourth quarter. CWA Asset Management Group LLC now owns 9,555 shares of the company’s stock worth $4,461,000 after buying an additional 8,733 shares during the last quarter. 62.73% of the stock is owned by institutional investors.

HCA Healthcare Price Performance

Shares of HCA Healthcare stock opened at $406.45 on Friday. The company’s fifty day simple moving average is $397.56 and its 200-day simple moving average is $460.39. HCA Healthcare, Inc. has a 1-year low of $330.00 and a 1-year high of $556.52. The stock has a market capitalization of $90.17 billion, a PE ratio of 13.98, a P/E/G ratio of 1.30 and a beta of 1.12.

HCA Healthcare (NYSE:HCA) last posted its quarterly earnings data on Friday, April 24th. The company reported $7.15 EPS for the quarter, missing the consensus estimate of $7.19 by ($0.04). HCA Healthcare had a negative return on equity of 295.93% and a net margin of 8.89%.The company had revenue of $19.11 billion during the quarter, compared to the consensus estimate of $19.09 billion. During the same period last year, the business earned $6.45 EPS. The firm’s quarterly revenue was up 4.3% compared to the same quarter last year. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. As a group, research analysts anticipate that HCA Healthcare, Inc. will post 30.07 EPS for the current year.

HCA Healthcare Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Tuesday, June 30th. Investors of record on Tuesday, June 16th were issued a $0.78 dividend. The ex-dividend date of this dividend was Tuesday, June 16th. This represents a $3.12 annualized dividend and a yield of 0.8%. HCA Healthcare’s dividend payout ratio is currently 10.73%.

Analyst Ratings Changes

Several equities research analysts recently weighed in on the stock. Wall Street Zen downgraded shares of HCA Healthcare from a “buy” rating to a “hold” rating in a research report on Saturday, May 2nd. Argus reduced their target price on HCA Healthcare from $560.00 to $500.00 and set a “buy” rating for the company in a report on Monday, May 4th. Stephens reduced their price objective on HCA Healthcare from $560.00 to $530.00 and set an “overweight” rating for the company in a report on Monday, April 27th. KeyCorp dropped their price target on shares of HCA Healthcare from $550.00 to $510.00 and set an “overweight” rating on the stock in a report on Monday, April 27th. Finally, Robert W. Baird lowered their price objective on shares of HCA Healthcare from $450.00 to $442.00 and set a “neutral” rating on the stock in a research report on Wednesday, April 15th. Fourteen investment analysts have rated the stock with a Buy rating, nine have given a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, HCA Healthcare currently has an average rating of “Moderate Buy” and an average price target of $497.14.

HCA Healthcare Company Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.